Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05685485 · ClinicalTrials.gov registry record
Tied Tube Trial in Glaucoma Surgery
A clinical trial of Glaucoma Eye and Ahmed Glaucoma Valve Implantation, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 152
- Enrollment target
- 1
- Study location
NCT05685485: Recruiting study of Glaucoma Eye and Ahmed Glaucoma Valve Implantation, sponsored by Washington University School of Medicine.
NCT05685485 is a study of Glaucoma Eye and Ahmed Glaucoma Valve Implantation that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 152 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05685485, a study of Glaucoma Eye and Ahmed Glaucoma Valve Implantation, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.
Conditions Studied
Interventions
- PROCEDURE Standard Implantation
- PROCEDURE Tied off Tube
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2022-10-18 |
| Est. Completion | 2025-01-31 |
What NCT05685485 shows while recruiting
NCT05685485 is an observational study that tracks outcomes without assigning an intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Glaucoma Eye appearing as the primary indexed condition, and to 2 interventions - of which Standard Implantation is the first listed.
NCT05685485 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05685485 about?
NCT05685485 is a clinical study titled "Tied Tube Trial in Glaucoma Surgery". The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at Wash...
What is the current status of trial NCT05685485?
This trial is currently recruiting. The enrollment target is 152 participants. The study started on 2022-10-18. Estimated completion is 2025-01-31.
What conditions does trial NCT05685485 study?
This clinical trial studies the following conditions: Glaucoma Eye, Ahmed Glaucoma Valve Implantation.
What interventions are being tested in trial NCT05685485?
The interventions under investigation include: Standard Implantation (PROCEDURE), Tied off Tube (PROCEDURE).
Who is sponsoring clinical trial NCT05685485?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05685485 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI